Montelukast is a selective CysLT1 leukotriene receptor antagonist, orally active, that inhibits pulmonary bronchoconstriction in asthma and exercise-induced asthma as well as inflammation in allergy-caused rhinitis.
Rabloc
Hypolipemiant. IHMG-CoA reductase inhibitor. Indicated to treat hypercholesterolemia, dyslipidemias, dysbetalipoproteinemia and for the prevention of more severe cardiovascular events in patients at high cardiovascular risk.
